23andMe Is Under Fire. Its Founder Remains ‘Optimistic’
You had an exclusive partnership with GlaxoSmithKline for five years, from 2018 to 2023. How successful was that? It was overwhelmingly productive. Fifty drug targets came out of it, far …
